Case 1:21-md-03017-RGA-LDH Document 325 Filed 10/25/24 Page 1 of 2 PageID #:
`1603
`
`
`
`IN THE UNITED STATES DISTRICT COURT
`FOR THE DISTRICT OF DELAWARE
`
`
`
`MDL NO. 21-MD-3017 (RGA)
`
`
`
`
`
`
`
`C.A. No. 23-1103 (RGA)
`
`
`
`
`
`)
`)
`)
`)
`)
`)
`)
`)
`)
`)
`)
`)
`)
`
`)))
`
`
`)
`)
`
`
`IN RE: XARELTO (RIVAROXABAN) ’310
`PATENT LITIGATION
`
`
`BAYER INTELLECTUAL PROPERTY GMBH,
`BAYER PHARMA AG, BAYER AG, and
`JANSSEN PHARMACEUTICALS, INC.,
`
`
`
`
`
`AUSON PHARMACEUTICALS INC. and
`SHANGHAI AUSON PHARMACEUTICALS
`CO., LTD.,
`
`
`
`
`
`
`
`
`
`
`Plaintiffs,
`
`
`
`v.
`
`
`
`Defendants.
`
`
`
`
`STIPULATION OF DISMISSAL
`
`Pursuant to Rules 41(a)(l) and 41(c) of the Federal Rules of Civil Procedure, Plaintiffs
`
`Bayer Intellectual Property GmbH, Bayer Pharma AG, Bayer AG, and Janssen Pharmaceuticals,
`
`Inc. (collectively, “Plaintiffs”) and Defendants Shanghai Auson Pharmaceuticals Co., Ltd. and
`
`Auson Pharmaceuticals Inc. (“Auson”), hereby stipulate and agree that Plaintiffs’ action against
`
`Auson and Auson’s action against Plaintiffs, including all claims and defenses asserted by
`
`Plaintiffs against Auson and all claims and defenses asserted by Auson against Plaintiffs, are
`
`hereby dismissed with prejudice. All parties shall bear their own costs, disbursements and
`
`attorneys’ fees.
`
`
`
`

`

`Case 1:21-md-03017-RGA-LDH Document 325 Filed 10/25/24 Page 2 of 2 PageID #:
`1604
`
`MORRIS, NICHOLS, ARSHT & TUNNELL LLP
`
`FOX ROTHSCHILD LLP
`
`/s/ Derek J. Fahnestock
`
`/s/ Kasey H. DeSantis
`
`Kasey H. DeSantis (#5882)
`1201 North Market Street, Suite 1200
`Wilmington, DE 19801
`(302) 622-4205
`kdesantis@foxrothschild.com
`
`Attorneys for Defendants
`Auson Pharmaceuticals Inc. and
`Shanghai Auson Pharmaceuticals Co., Ltd.
`
`Jack B. Blumenfeld (#1014)
`Rodger D. Smith II (#3778)
`Derek J. Fahnestock (#4705)
`1201 North Market Street
`P.O. Box 1347
`Wilmington, DE 19899
`(302) 658-9200
`jblumenfeld@ morrisnichols.com
`rsmith@ morrisnichols.com
`dfahnestock@ morrisnichols.com
`
`Attorney for Plaintiffs Bayer Intellectual
`Property GmbH, Bayer Pharma AG, Bayer
`AG, and Janssen Pharmaceuticals, Inc.
`
` October 24, 2024
`
`25
`October
`SO ORDERED this ___ day of _____________________, 2024.
`
`/s/ Richard G. Andrews
`UNITED STATES DISTRICT JUDGE
`
`2
`
`

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.

We are unable to display this document.

PTO Denying Access

Refresh this Document
Go to the Docket